Series Title | EurActiv |
---|---|
Series Details | 22.10.13 |
Publication Date | 22/10/2013 |
Content Type | News |
Europe's medicines regulator has come out fighting for greater transparency for clinical trials, arguing that its controversial policy to end data secrecy will be "a boon to drug developers". The strong defence of greater openness by the boss of the European Medicines Agency (EMA) and colleagues comes as the agency battles a lawsuit from two U.S. drugmakers over its plans to release data on their medicines. |
|
Source Link | Link to Main Source http://www.euractiv.com/health/drug-trial-secrecy-boon-rd-eu-ag-news-531216 |
Related Links |
|
Subject Categories | Health |
Countries / Regions | Europe |